---
title: Glycoprotein modeling of Erythropoietin (EPO) with Re-Glyco
---


# Erythropoietin (EPO)

Erythropoietin, also known as erythropoetin, haematopoietin, or haemopoietin, is a  glycoprotein cytokine secreted mainly by the kidneys in response to  cellular hypoxia; it stimulates red blood cell production in the bone  marrow.

<div style="display: flex; align-items: flex-start; gap: 20px;">
    <div style="flex: 1;">
        <img src="EPO\Lance_Armstrong.png" alt="Sample Image" style="width: 100%; height: auto;">
    </div>
    <div style="flex: 1;">
        <iframe src="https://glycoshape.org/viewer/embedded.html?pdbUrl=https://raw.githubusercontent.com/Ojas-Singh/GlycoShape-Resources/refs/heads/main/tutorials/EPO/glycosylated_model.pdb&format=pdb" width="100%" height="500px" frameborder="0"></iframe>
    </div>
</div>

*Lance Armstrong, the seven-time Tour de France winner, was at the center of one of cycling's biggest doping scandals involving EPO. Armstrong systematically used EPO to boost his red blood cell count and enhance oxygen delivery to his muscles, giving him a significant competitive advantage. His eventual admission to EPO use led to the stripping of all his Tour de France titles and a lifetime ban from competitive cycling.*

**UniProt ID:** <mark>P01588 Â· EPO_HUMAN</mark>

For detailed protein information, visit the [UniProt entry](https://www.uniprot.org/uniprotkb/P01588/entry).

Before proceeding, download the PDB file:  
<a href="https://raw.githubusercontent.com/Ojas-Singh/GlycoShape-Resources/refs/heads/main/tutorials/EPO/rEPO_ChainA.pdb" download="rEPO_ChainA.pdb">rEPO_ChainA.pdb</a>

# Upload the PDB file to Re-Glyco

<div style="display: flex; justify-content: space-between; align-items: center;">
    <div style="flex: 1; text-align: center;">
        <img src="EPO\glycoshape.org-GlycoShapeGlycanStructureDatabase.png" alt="G55818EE structure" width="80%">
        <p><em>Re-Glyco</em></p>
    </div>
    <div style="flex: 1; text-align: center;">
        <img src="EPO\glycoshape.org-GlycoShapeGlycanStructureDatabase(1).png" alt="G55818EE structure" width="80%">
        <p><em>EPO loaded</em></p>
    </div>
</div>

# GlcNAc Scan to find the possible N-Glycosylation sites

<div style="text-align: center;">
    <img src="EPO\glycoshape.org-GlycoShapeGlycanStructureDatabase(2).png" alt="Simulation of G55818EE" width="40%" >
    <p><em>Simulation of G55818EE glycan dynamics</em></p>
</div>


# Add G55818EE on all N-glycosylation sites

<div style="text-align: center;">
    <img src="EPO\glycoshape.org-GlycoShapeGlycanStructureDatabase(3).png" alt="Simulation of G55818EE" width="40%" >
    <p><em>Simulation of G55818EE glycan dynamics</em></p>
</div>

# Switch to Re-Glyco Ensemble

<div style="display: flex; justify-content: space-between; align-items: center;">
    <div style="flex: 1; text-align: center;">
        <img src="EPO\glycoshape.org-GlycoShapeGlycanStructureDatabase(4).png" alt="G55818EE structure" width="80%">
        <p><em>Re-Glyco</em></p>
    </div>
    <div style="flex: 1; text-align: center;">
        <img src="EPO\glycoshape.org-GlycoShapeGlycanStructureDatabase(5).png" alt="G55818EE structure" width="80%">
        <p><em>EPO loaded</em></p>
    </div>
</div>
